# Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions

> **NCT05305612** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **National Institute of Cardiology, Warsaw, Poland** · enrollment: 410 (estimated)

## Conditions studied

- Mitral Regurgitation
- Atrial Fibrillation
- Anticoagulation

## Interventions

- **OTHER:** early anticoagulation
- **OTHER:** late anticoagulation

## Key facts

- **NCT ID:** NCT05305612
- **Lead sponsor:** National Institute of Cardiology, Warsaw, Poland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-03-13
- **Primary completion:** 2025-05
- **Final completion:** 2025-08
- **Target enrollment:** 410 (ESTIMATED)
- **Last updated:** 2024-12-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05305612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05305612, "Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05305612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*